The idea behind Truemeds emerged from a simple but persistent issue in India’s pharmaceutical market: patients often pay very different prices for medicines that are chemically identical. This gap is most visible among people managing chronic conditions, who take medicines over long periods and face recurring monthly expenses. The founders of Truemeds observed that in many cases, higher costs were linked more to branding, promotions and marketing costs than to differences in formulation or quality.

Truemeds was founded by Akshat Nayyar and Dr. Kunal Wani, who approached the problem from complementary perspectives spanning healthcare operations and clinical practice. Through their early interactions with patients and prescriptions, they noted that while multiple approved brands existed for the same medicine, patients were rarely informed about these alternatives. Even when lower-priced options were available, hesitation around switching was common, largely due to concerns about effectiveness and a lack of medical guidance.